Deborah J. Andrews

This profile gathers the share dealings of Deborah J. Andrews across 2 companies, led by Staar Surgical Co and Lineage Cell Therapeutics, Inc. Between 6 September 2006 and 14 August 2026, the trades on record add up to 89 filings.

The open-market side counts 5 purchases for €24k alongside 42 sales for €5.9M. On balance, insiders were net sellers of €5.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants and 28 option exercises.

In size, the median ticket on the buying side is €5,071. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 5 purchases with a full 90-day history, the hit rate stands at 20% and the median 90-day move at -11.1%. They describe history only and say nothing certain about the share price ahead.

On 18 August 2026 came the latest disclosure, an option exercise in Staar Surgical Co. The clock since the last published purchase (13 September 2018) now reads 2,978 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.